Clay Siegall is the CEO of Seattle Genetics. (Dan Bates / Herald file)

Clay Siegall is the CEO of Seattle Genetics. (Dan Bates / Herald file)

Bothell’s Seattle Genetics to acquire Cascadian Therapeutics for $614M

Deal would be merger between two Puget Sound area biotech companies developing cancer treatments.

You must sign in or register to continue reading content.

More in Herald Business Journal

Boeing leases aerospace gallery with lofty improvement plans

The company is expected to invest millions of dollars in the former Future of Flight Aviation Center.

Goal is 20,000 jobs by 2040 in Arlington-Marysville center

A public meeting is set for 5 to 7 p.m. Wednesday to discuss a big plan for industrial growth.

Paul Allen’s $26 billion estate will take years to unravel

Allen, who died Monday, had no spouse or children to divide his empire.

Boeing’s new biz targets computers modeled on human brains

Neuromorphic processing and quantum communications form the core of aerospace innovation.

Long-time Chinese Boeing client in talks with Airbus

An Airbus contract, a risk of Trump’s effort to curtail China’s economic rise, would be a blow to Boeing.

Bothell man, others charged with insurance fraud

An investigation concluded the accident he collected on occurred before he applied for his policy.

StarKist admits fixing tuna prices, faces $100 million fine

Bumble Bee Foods last year pleaded guilty to the same charge and paid a $25 million fine.

Former Microsoft director indicted on embezzlement charges

He is accused of selling Super Bowl tickets intended for employees and trying to steal $1.5 million.

Army Corps revives review of Washington coal-export project

The state last fall denied Millennium Bulk Terminals-Longview a key permit needed for the project.

Most Read